Mr Henry J Cain MBChB (hons) FRCS, MD
Henry Cain qualified in 2001 from Leicester Medical School. Following the award of MD in breast cancer signalling pathways and higher surgical training in Newcastle upon Tyne he spent a year as the Oncoplastic Fellow at the Canniesburn Unit in Glasgow. He was appointed a Consultant Oncoplastic Surgeon at the Royal Victoria Infirmary Newcastle upon Tyne in 2013. Driving improvements in surgical care he has led the introduction of Radioactive Seed Localisation of impalpable breast cancer and post neo-adjuvant chemotherapy I125 seed Targeted Axillary Dissection to the UK. With a significant recruitment into national trials he is the surgical lead Co-Investigator for the NOSTRA trial and the Chief Investigator for the PRE-DX national RCT.